Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Statement

23 Mar 2020 07:00

RNS Number : 1202H
Electrocomponents PLC
23 March 2020
 

Electrocomponents plc today issues a pre-close trading update for the year ending 31 March 2020 and an update on COVID-19, ahead of reporting full-year results in May 2020.

COVID-19 update

As we closely monitor the impact of COVID-19, our priority is to safeguard the health and wellbeing of our employees and to continue to support our customers and suppliers across the globe. As we do so, we are adhering to advice from government health agencies including the World Health Organisation.

In January we formed a central crisis management team to manage our response to the outbreak in Asia Pacific and our experience there has meant that we have been able to quickly implement business continuity plans across the globe. These plans include:

· Monitoring inventory and our supply chain to ensure consistency of supply,

· Building continuity plans for our distribution centres, and

· Extensive home working for our office-based teams.

These plans are working well and the response of our people has been outstanding. At the present time, all our distribution centres around the world remain open and operating effectively, with the exception of our distribution centres in France and Italy. We are currently servicing our French and Italian customers out of the UK. Our online business model continues to differentiate us and has helped us maintain service levels to our customers which include critical industries such as the public sector, food and beverage, power generation and utilities. However, whilst we continue to be able to manage the supply side, there is now evidence that increasing restrictions in some of our major markets are impacting demand. 

Current trading

Up to and including the week ended 15 March 2020, the Group saw limited impact from COVID-19 on levels of customer demand.

· Group like-for-like(1) revenue growth in the 11-week period ended 15 March was c. 4%.

· All three regions saw positive like-for-like revenue growth across the period, with EMEA up 3%, Americas up 3% and Asia Pacific strongly up 11%.

While market conditions are changing rapidly and it is difficult to draw conclusions from a single week of trading, it is notable that in the week ended 22 March like-for-like Group revenue growth has slowed to a high single-digit decline. Revenue trends have worsened across the week and volume levels vary considerably between markets. Those markets where public mobility has been most restricted, such as Italy and France, are seeing the largest impact with volumes down significantly driven primarily by lower demand. Other markets, where restrictions are only just now being implemented, such as the UK and US, are seeing a more modest impact on revenue at this stage.

While we currently expect to deliver adjusted(2) PBT for the year ending 31 March 2020 around the bottom end of our current market consensus(3) range, it remains a rapidly evolving situation. It remains too early to assess the impact that the unfolding COVID-19 situation will have on trading in the year ending 31 March 2021.

Balance sheet and liquidity

We enter this period of uncertainty in a strong financial position with a cash generative business model.

· At 30 September 2019 net debt to adjusted EBITDA was 0.9 times and adjusted EBITA to interest was over 40 times.

· Our financial covenants are net debt to adjusted EBITDA < 3.25 times and adjusted EBITA to interest of > 3 times.

· Net debt on 29 February 2020 was £209 million (including £57 million of lease liabilities), down from £221 million at 30 September 2019.

· Current committed facilities amount to £380 million, with over £340 million of these facilities maturing beyond July 2022. As of 29 February 2020, c.£180 million of our facilities are undrawn.

Mitigating actions

In anticipation of lower demand levels in the short term we are acting now to protect profitability and to conserve cash, while seeking to ensure the Group is well placed to benefit when the recovery takes place. We are reviewing all discretionary expenditure, both operating and capital, and considering suitable government assistance programmes in the markets in which we operate to preserve the productive capacity of the business as far as possible.

We will continue to support the needs of all our customers, suppliers and employees through this challenging period. Electrocomponents is also assisting the fight against COVID-19 by supporting one of the UK manufacturing consortia as they seek to rapidly develop new medical ventilation equipment.

Overall

The Group's strong financial position, coupled with our differentiated online business model, global distribution network and strong supplier relationships, means that we remain well positioned to weather the present crisis and to continue driving growth and market share gains over the medium term.

LEI: 549300KVXDURRKVWR37

 

Enquiries:

David Egan

Chief Financial Officer

020 7239 8400

Polly Elvin

Head of Investor Relations

020 7239 8427

Martin Robinson/ Lisa Jarrett-Kerr

Tulchan Communications

020 7353 4200

 

Notes:

1. Like-for-like revenue growth is growth in revenue adjusted to eliminate the impact of acquisitions, changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2019 is converted at 2020 average exchange rates for the period.  

2. Adjusted excludes amortisation of intangible assets arising on acquisition of businesses, substantial reorganisation costs, substantial asset write-downs, one-off pension credits or costs, significant tax rate changes and associated income tax.

3. The current consensus range for adjusted PBT for the year ending 31 March 2020 is ÂŁ209.2 million to ÂŁ216.0 million.

4. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2019 for euro and US$ respectively were €1.13 and $1.31 respectively. Every 1 cent movement in the euro has a circa £1.4 million impact on annual profit. Every 1 cent movement in the US $ has a circa £0.5 million impact on annual profit.  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFFFSIVSIFFII
Date   Source Headline
7th Mar 20173:43 pmRNSDirector Declaration
1st Mar 201712:28 pmRNSTotal Voting Rights
15th Feb 20172:48 pmRNSDirector/PDMR Shareholding
10th Feb 20177:00 amRNSTrading update
1st Feb 20172:15 pmRNSHolding(s) in Company
1st Feb 201710:37 amRNSBlock listing Interim Review
31st Jan 201710:33 amRNSTotal Voting Rights
23rd Jan 201711:59 amRNSHolding(s) in Company
13th Jan 20174:01 pmRNSNotice of trading update
3rd Jan 201711:41 amRNSTotal Voting Rights
21st Dec 20167:00 amRNSDirectorate Change
9th Dec 201610:28 amRNSHolding(s) in Company
1st Dec 201611:12 amRNSTotal Voting Rights
18th Nov 20167:00 amRNS2017 Half-year Financial Results
14th Nov 201612:37 pmRNSHolding(s) in Company
31st Oct 20161:37 pmRNSTotal Voting Rights
7th Oct 20163:47 pmRNSHolding(s) in Company
4th Oct 20161:25 pmRNSHolding(s) in Company
30th Sep 201610:12 amRNSTotal Voting Rights
15th Sep 20162:48 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSTrading Statement
12th Sep 20167:00 amRNSDirectorate Change
1st Sep 201610:19 amRNSTotal Voting Rights
1st Aug 20169:42 amRNSBlock listing Interim Review
29th Jul 20162:50 pmRNSDirector/PDMR Shareholding
29th Jul 201611:35 amRNSTotal Voting Rights
22nd Jul 20169:23 amRNSDirector/PDMR Shareholding
20th Jul 201612:43 pmRNSResult of AGM
20th Jul 20167:00 amRNSDirectorate Change
20th Jul 20167:00 amRNSTrading Statement
5th Jul 201612:06 pmRNSNotice of Trading Update
30th Jun 201611:28 amRNSTotal Voting Rights
27th Jun 201611:39 amRNSDirector/PDMR Shareholding
23rd Jun 20161:04 pmRNSDirector/PDMR Shareholding
20th Jun 201610:40 amRNSDirector/PDMR Shareholding
16th Jun 20169:44 amRNSAnnual Financial Report
31st May 201610:45 amRNSTotal Voting Rights
23rd May 201610:40 amRNSHolding(s) in Company
19th May 20167:00 amRNSFinal Results
29th Apr 201610:00 amRNSTotal Voting Rights
5th Apr 20167:00 amRNSTrading Update
1st Apr 20167:00 amRNSTotal Voting Rights
31st Mar 20167:00 amRNSDirectorate Change
29th Mar 201611:34 amRNSHolding(s) in Company
18th Mar 201612:03 pmRNSDirector/PDMR Shareholding
18th Mar 20169:53 amRNSNotice of trading update
14th Mar 201611:37 amRNSDirector/PDMR Shareholding
1st Mar 20169:22 amRNSTotal Voting Rights
10th Feb 20167:00 amRNSTrading Statement
1st Feb 201610:41 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.